Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine. In a commentary published in the journal Diabetes Research and Clinical Practice, Miller School of Medicine professor and endocrinologist Gianluca Iacobellis, M.D., Ph.D., suggests the DPP4 enzyme presents an interesting target for further research, and DPP4 inhibitors could help some COVID-19 patients.
- Long-term strategies to control COVID-19 must treat health and economy as equally important
- Cigarette sales declining by 20 million a month after advent of standardized packaging
- Jurassic fossils from northeastern China reveal morphological stasis in the catkin-yew
- Columbia physicians give first comprehensive review of COVID-19’s effects outside the lung
- Couldn’t socially distance? Blame your working memory